Holen Sie sich die Stockscreener-App
382.46
0.42%
-1.60
Handel nachbörslich:
382.46
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SYK?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$384.06
Offen:
$383.96
24-Stunden-Volumen:
926.65K
Relative Volume:
0.59
Marktkapitalisierung:
$142.93B
Einnahmen:
$23.22B
Nettoeinkommen (Verlust:
$2.86B
KGV:
51.68
EPS:
7.4
Netto-Cashflow:
$3.58B
1W Leistung:
+2.26%
1M Leistung:
+13.37%
6M Leistung:
+1.73%
1J Leistung:
+16.15%
1-Tages-Spanne:
$382.36
$388.32
1-Wochen-Bereich:
$363.08
$388.32
52-Wochen-Spanne:
$314.93
$406.19
Stryker Corp Stock (SYK) Company Profile
Firmenname
Stryker Corp
Sektor
Branche
Telefon
(269) 385-2600
Adresse
1941 STRYKER WAY, PORTAGE, MI
Vergleichen Sie SYK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
382.46 | 142.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
ABT
Abbott Laboratories
|
134.00 | 227.71B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.29 | 152.66B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
83.62 | 107.17B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.63 | 44.04B | 5.54B | 4.18B | 623.10M | 7.00 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-26 | Fortgesetzt | Citigroup | Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Outperform |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-01-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-25 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-28 | Hochstufung | Edward Jones | Hold → Buy |
| 2022-07-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-07-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-10-06 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Herabstufung | Goldman | Buy → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Hold |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Bestätigt | BTIG Research | Buy |
| 2019-11-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-07-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-16 | Eingeleitet | BTIG Research | Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-27 | Bestätigt | Stifel | Buy |
Alle ansehen
Stryker Corp Aktie (SYK) Neueste Nachrichten
Stryker declares an $0.84 per share quarterly dividend - Ortho Spine News
Stryker (SYK) Announces Steady Dividend with Promising Growth Forecast - GuruFocus
Stryker raises dividend to $0.84 per share for Q2 - Investing.com
Stryker Declares An $0.84 Per Share Quarterly Dividend - Barchart.com
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today - Benzinga
Stryker (SYK) Receives Price Target Boost Following Strong Quart - GuruFocus
Stryker, Lockheed Martin, Rockwell Automation And More On CNBC's 'Final Trades' - Benzinga
Reflecting On Medical Devices & SuppliesDiversified Stocks’ Q1 Earnings: Stryker (NYSE:SYK) - Yahoo Finance
Stryker (SYK) Price Target Raised by Truist Securities | SYK Sto - GuruFocus
Stryker (SYK) Price Target Raised by Truist Securities | SYK Stock News - GuruFocus
UBS lifts Stryker stock price target to $421 from $405 - Investing.com
Stryker's (SYK) Price Target Raised by Truist Amid Strong Growth - GuruFocus
Demystifying Stryker: Insights From 5 Analyst Reviews - Benzinga
Stryker's (SYK) Price Target Raised by Truist Amid Strong Growth | SYK Stock News - GuruFocus
Stryker (SYK) Receives Price Target Boost Following Strong Quarterly Results | SYK Stock News - GuruFocus
Decoding Stryker Corp (SYK): A Strategic SWOT Insight - GuruFocus
Stryker Corp’s Earnings Call Highlights Robust Growth - TipRanks
Stryker price target raised to $456 from $405 at Roth Capital - TipRanks
Stryker says bribery probe dropped by US Justice Department - MLex
Stryker (SYK) Lands a Higher Price Target from Roth MKM | SYK Stock News - GuruFocus
Stryker (SYK) Rating Maintained, Price Target Lowered by Evercore ISI Group | SYK Stock News - GuruFocus
Stryker (SYK): Roth Capital Boosts Price Target Amid Strong Q1 P - GuruFocus
Medical Equipment Makers Stryker, Becton Eye Price Hikes to Offset Tariffs - Bloomberg.com
Stryker (SYK): Roth Capital Boosts Price Target Amid Strong Q1 Performance | SYK Stock News - GuruFocus
Stryker raises forecast on strong sales despite $200M tariff hit - Crain's Grand Rapids Business
Stryker Corporation (SYK) Sees Strong Q1 2025 Growth Amid Strate - GuruFocus
Stryker Corporation (NYSE:SYK) Q1 2025 Earnings Call Transcript - Insider Monkey
Stryker stock target cut to $390 by Evercore ISI - Investing.com
Stryker beats quarterly estimates of string medical device demand - Reuters
Stryker Corp Reports Strong Q1 2024 Earnings Growth - TipRanks
Stryker Corp (SYK) Q1 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ... - Yahoo Finance
Stryker Corp (SYK) Q1 2025 Earnings: Revenue Surpasses Estimates at $5.9 Billion, EPS Falls Short at $1.69 - GuruFocus
Stryker Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Stryker: Q1 Earnings Snapshot - MySA
Stryker Corporation (SYK) Sees Strong Q1 2025 Growth Amid Strategic Shifts - GuruFocus
Stryker's Profits Outshine Forecasts Thanks To Device Demand - Finimize
Earnings call transcript: Stryker Q1 2025 beats EPS forecasts, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: Stryker Q1 2025 beats EPS forecasts, stock dips - Investing.com
Stryker reports first quarter 2025 operating results - ADVFN
Stryker (SYK) Surpasses Q1 Earnings and Revenue Estimates - Yahoo
Stryker earnings beat by $0.13, revenue topped estimates - Investing.com
SYK Reports Strong Q1 Revenue, Beating Expectations | SYK Stock News - GuruFocus
Stryker beats Q1 estimates, raises 2025 organic sales outlook By Investing.com - Investing.com India
Stryker beats Q1 estimates, raises 2025 organic sales outlook - Investing.com
Stryker Corp. Q1 Profit Decreases, But Beats Estimates - Nasdaq
Here's How Much $1000 Invested In Stryker 10 Years Ago Would Be Worth Today - Benzinga
Global Spinal Stenosis Devices Market to reach USD 4,131.08 million at a CAGR of 4.83% by 2030, Evaluates DelveInsight | Spinal Simplicity, Boston Scientific Corporation, Medtronic, Stryker, Surgalig - Barchart.com
Stryker (SYK) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference - Yahoo Finance
Stryker Corporation (SYK): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential - Insider Monkey
Stryker (SYK) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Finanzdaten der Stryker Corp-Aktie (SYK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.44%
0.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):